A. A. Green

627 total citations
10 papers, 506 citations indexed

About

A. A. Green is a scholar working on Neurology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. A. Green has authored 10 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. A. Green's work include Neuroblastoma Research and Treatments (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Cancer therapeutics and mechanisms (1 paper). A. A. Green is often cited by papers focused on Neuroblastoma Research and Treatments (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Cancer therapeutics and mechanisms (1 paper). A. A. Green collaborates with scholars based in United States. A. A. Green's co-authors include Erlinda Etcubanas, E C Douglass, P.J. Houghton, Bruce L. Webber, David M. Parham, Mark C. Valentine, F. Ann Hayes, Marc E. Horowitz, Janet A. Houghton and Peter J. Houghton and has published in prestigious journals such as Journal of Clinical Oncology, Bone Marrow Transplantation and Cancer Chemotherapy and Pharmacology.

In The Last Decade

A. A. Green

10 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. A. Green United States	7	259	195	146	133	118	10	506
Richard J. Dahl United States	12	130 0.5×	280 1.4×	127 0.9×	122 0.9×	113 1.0×	16	762
Matthew C. Cayouette United States	8	120 0.5×	182 0.9×	255 1.7×	211 1.6×	350 3.0×	8	711
Violetta Barbashina United States	12	201 0.8×	235 1.2×	227 1.6×	60 0.5×	112 0.9×	21	595
A Pagès France	9	105 0.4×	165 0.8×	100 0.7×	55 0.4×	67 0.6×	37	453
Arthur A. Glatfelter United States	10	324 1.3×	218 1.1×	114 0.8×	35 0.3×	75 0.6×	14	615
Mirjam F. Mastik Netherlands	14	283 1.1×	233 1.2×	175 1.2×	84 0.6×	97 0.8×	28	656
Jeffrey R. Sawyer United States	9	221 0.9×	194 1.0×	86 0.6×	33 0.2×	59 0.5×	10	474
Susanne V. Allander Sweden	12	257 1.0×	302 1.5×	140 1.0×	30 0.2×	131 1.1×	18	728
Haruhiro Sato Japan	14	150 0.6×	155 0.8×	87 0.6×	53 0.4×	57 0.5×	34	515
Klaus-Peter Kuenkele Germany	3	152 0.6×	135 0.7×	95 0.7×	50 0.4×	83 0.7×	5	353

Countries citing papers authored by A. A. Green

Since Specialization

Citations

This map shows the geographic impact of A. A. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. Green more than expected).

Fields of papers citing papers by A. A. Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. A. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. Green. The network helps show where A. A. Green may publish in the future.

Co-authorship network of co-authors of A. A. Green

This figure shows the co-authorship network connecting the top 25 collaborators of A. A. Green. A scholar is included among the top collaborators of A. A. Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. Green. A. A. Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Cohn, Susan L., et al.. (1997). Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescue. Bone Marrow Transplantation. 20(7). 543–551. 37 indexed citations

McWilliams, Nancy B., F. Ann Hayes, A. A. Green, et al.. (1995). Cyclophosphamide/doxorubicin vs. Cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: A pediatric oncology group randomized phase II study. Medical and Pediatric Oncology. 24(3). 176–180. 18 indexed citations

Hayes, F. Ann, A. A. Green, & Dennis M. O’Connor. (1989). Chemotherapeutic management of epidural neuroblastoma. Medical and Pediatric Oncology. 17(1). 6–8. 25 indexed citations

Meyer, William H., Peter J. Houghton, Marc E. Horowitz, et al.. (1989). Use of Investigational Drugs as Initial Therapy for Childhood Solid Tumors. Hämatologie und Bluttransfusion. 32. 141–148. 4 indexed citations

Pratt, C B, E C Douglass, Erlinda Etcubanas, et al.. (1989). Ifosfamide in pediatric malignant solid tumors. Cancer Chemotherapy and Pharmacology. 24(S1). S24–7. 36 indexed citations

Horowitz, Marc E., Erlinda Etcubanas, Michael L. Christensen, et al.. (1988). Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma: a model for anticancer drug development.. Journal of Clinical Oncology. 6(2). 308–314. 91 indexed citations

Douglass, E C, Mark C. Valentine, Erlinda Etcubanas, et al.. (1987). A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenetic and Genome Research. 45(3-4). 148–155. 274 indexed citations

Hayes, F. Ann, Minnie Abromowitch, & A. A. Green. (1985). Allergic reactions to teniposide in patients with neuroblastoma and lymphoid malignancies.. PubMed. 69(4). 439–41. 18 indexed citations

Houghton, Peter J., Janet A. Houghton, Garrett M. Brodeur, & A. A. Green. (1981). Characterization, chemosensitivity and drug resistance in xenografts of human childhood rhabdomyosarcomas (RMS). Proceedings of the American Association for Cancer Research. 22. 2 indexed citations

10.

Borella, Luis, A. A. Green, Rhomes J. A. Aur, J. V. Simone, & Donald Pinkel. (1973). Clinical and Immunological Recovery of Children with Acute Lymphocytic Leukemia Admitted to “Total Therapy” Studies. PubMed. 43. 145–150. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact